Perrigo Company PRGO
-
Perrigo ([[ PRGO ]] -0.2%) has received final FDA approval for its abbreviated new drug application for Lansoprazole capsules for the treatment of frequent heartburn. Shipments of the product to ...
Perrigo ( PRGO -0.2% ) has received final FDA approval for its abbreviated new drug application for Lansoprazole capsules for the treatment …
-
Perrigo's CEO Discusses Q3 2012 Results - Earnings Call Transcript
Perrigo ( PRGO ) Q3 2012 Earnings Call May 08, 2012 10:00 am ET Executives Arthur J. Shannon - Vice President of Investor Relations & Communication …
-
Margin Expansion Helps Perrigo Overcome Weaker-Than-Expected Revenue Growth
Perrigo's PRGO reported fiscal third-quarter revenue growth of 13% fell below our expectations, but slightly better-than-expected margin …
-
Perrigo Company PRGO Q3 2012 Earnings Call Transcript
Good morning. My name is Lamitris, and I will be your conference operator today. At this time, I would like to welcome everyone to the Perrigo's Fiscal 2012 Third Quarter Earnings Results. All lines have been placed on mute to prevent any background noise. After the speakers' remarks, there will be
-
Notable earnings before Tuesday's open: [[AKRX]], [[ARCC]], [[CHTR]], [[DISCA]], [[DTV]], [[FOSL]], [[HCN]], [[HL]], [[HSIC]], [[IFF]], [[NVE]], [[ PRGO ]], [[SMG]], [[STWD]], [[TAP]], [[TDG]], ...
Notable earnings before Tuesday's open: AKRX , ARCC , CHTR , DISCA , DTV , FOSL , HCN , HL , HSIC , IFF , NVE , PRGO , SMG , STWD , TAP , TDG , THC , WEN Post your comment!
-
Tale Of 2 Public Companies: Taro Pharma And Perrigo
By Retail Investor : Taro Pharma ( TARO ) And Perrigo ( PRGO ): Both the companies are public. Shares of both the companies trade in reputed US exchanges. Both compete in generic Rx and …
-
Funds That Have Thrived on an Apple-Free Diet
… since 2009 from consumer products giants like Diageo DEO. Specialty drug companies like Valeant Pharmaceuticals VRX and Perrigo PRGO as well as discount retailer TJX Companies TJX have helped the venerable Sequoia SEQUX over the past three years; the key to …
-
Aggressive Growth Plan Sets Sunpeaks Ventures Up For Bright Future
By Jacob Wolinsky : I have received compensation to research Sunpeaks Ventures ( SNPK.OB ). Nevertheless, I have tried to write to the best of my ability an unbiased review of this company. Sunpeaks Ventures ( SNPK.OB ) has seen a spike in investor interest recently as it continues to execute on ...
-
New Morningstar Analyst Report - Perrigo Company
Johnson & Johnson's eventual return to the OTC market and a gradually improving economy should slow Perrigo's market share gains in its store-brand consumer health segment. As a store-brand OTC manufacturer to huge retail customers, Perrigo has little to no pricing power.International growth will
-
Cramer's Mad Money - We Don't Need No Education Stocks (3/1/12)
By SA Editor Miriam Metzinger : Stocks discussed on the in-depth session of Jim Cramer's Mad Money TV Program, Thursday March 1. We Don't Need No Education Stocks: Strayer ( STRA ), DeVry ( DV ), ITT Corporation ( ITT ), Apollo Group ( APOL ), Corinthian ( COCO ), Career Education ( CECO ), ...